Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Approx 3.5 million warrants expiring on August 14, 2024
View:
Post by Noteable on Aug 01, 2024 4:22pm

Approx 3.5 million warrants expiring on August 14, 2024

.
Comment by Noteable on Aug 14, 2024 2:03pm
Which happens to be today.
Comment by Noteable on Aug 14, 2024 7:38pm
And by ONCY beginning the process of enrolling between 180-200 patients in a monotherapy pelareorep + paclitaxel clinical/registration study ONCY speeds up the Accelerated Approval process by demonstrating to the FDA that ONCY is well into the implementation of a well designed clinical study, with FDA agreed upon primary and secondary endpoints, that have resulted in previous Accelerated Approvals ...more  
Comment by spesestsemper on Aug 14, 2024 4:40pm
Common Share Purchase Warrants As of the date hereof, we have 64,035 Common Share purchase warrants (the “2019 Warrants”) issued and outstanding. Each 2019 Warrant entitles the holder to purchase one common share at an exercise price of US$0.90 until August 16, 2024. As of the date hereof, we have 7,667,050 Common Share purchase warrants (the “2023 Warrants”) issued and outstanding. Each 2023 ...more  
Comment by Noteable on Aug 14, 2024 5:26pm
Keep looking .
Comment by Noteable on Aug 14, 2024 5:28pm
Different offering. Different time.
Comment by spesestsemper on Aug 14, 2024 6:11pm
well - the most recent filing had to contain anything that is out there . Please provide a link to the ones you are talking about .Are you saying they forgot to mention them in the filing ?
Comment by spesestsemper on Aug 14, 2024 6:13pm
Perhaps the ones you are talking about were excercised at one time and are no longer outstanding ?
Comment by Noteable on Aug 14, 2024 6:47pm
SAN DIEGO, CA and CALGARY, AB, August 14, 2019 -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) (the “Company”), currently developing pelareorep, an intravenously delivered immunooncolytic virus, provides an update to confirm that its previously announced underwritten public offering of USD $3.7M (CDN $4.9M) was priced at USD $0.81 (CDN $1.07) Each warrant has an exercise price of $0.90 ...more  
Comment by spesestsemper on Aug 14, 2024 6:51pm
well - it seems there is only 64,035 that haven't been exercised . The remainder must have been issused sometime in the past
Comment by Noteable on Aug 14, 2024 6:55pm
spesestsemper your nose is down the wrong hole. 
Comment by Noteable on Aug 14, 2024 6:53pm
4,619,773 warrants were issued and only 1,100,000 were exercised leaving approximately 3.5 million unexercised that expired today.
Comment by spesestsemper on Aug 14, 2024 6:56pm
where do you get that from - the filing states no such thing
Comment by Noteable on Aug 14, 2024 7:33pm
Well you're wrong. I suggest that you reading the various management discussions from August 2019 onward to see that only 1.1 million warrants were exercised and that 3.5 million remained until they expired today. Otherwise don't bother me.
Comment by Noteable on Aug 14, 2024 7:34pm
Should read : I suggest that you begin reading the various management discussions from August 2019 onward
Comment by spesestsemper on Aug 14, 2024 7:47pm
What you are saying is that the filings are wrong . Think about it for a minute , why would they only mention the 64035 from the 2019 . What? did  they just think not to mention the others . Your the one that made the statement of 3.5 million expiring today and you can't back that up with anything recent . I have to go by what the company filed . Think I will go by the filings other than ...more  
Comment by Noteable on Aug 14, 2024 7:57pm
What I'm saying is that you have no idea about what you're talking about. 
Comment by pelaboost on Aug 14, 2024 8:05pm
@september. Sometimes I am highly amused when Noteable gets a notion and is unable to let go. Tenacious. I am one of those that finds his posts informative. Or her posts. One cannot know. Do the math. We know about 7 million warrants from July 2023 financing, and Noteable has asserted none of those warrants have been exercised. That seems reasonable. Take the phantom 3.5 and look at the ONC ...more  
Comment by spesestsemper on Aug 14, 2024 7:55pm
Oncolytics Biotech(R) Announces Exercise of Warrants (accesswire.com) SAN DIEGO, CA and CALGARY, AB / ACCESSWIRE / November 12, 2019 / Oncolytics Biotech® Inc. (NASDAQ:ONCY) (TSX:ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced the exercise of warrants from it's August 2019 financing. The Company announced the ...more  
Comment by Noteable on Aug 14, 2024 7:59pm
Ok 3.2 million shares expiring today. Now bog off.
Comment by spesestsemper on Aug 14, 2024 8:00pm
I'm sure the others are there  somewhere . Not spending all night looking for you . I'll rely on the companies filings
Comment by Noteable on Aug 14, 2024 8:04pm
Why not keep looking? The reason is that you can't find anything to support anything you claim. Remember what you first said .. something about only 64 k warrants ?
Comment by spesestsemper on Aug 14, 2024 8:06pm
I'm not claiming anything - The filing states that . You are too stubborn to just read it and accept it . If you don't accept the filing - you must think the company filed it wrong .
Comment by spesestsemper on Aug 14, 2024 8:07pm
Common Share Purchase Warrants As of the date hereof, we have 64,035 Common Share purchase warrants (the “2019 Warrants”) issued and outstanding. Each 2019 Warrant entitles the holder to purchase one common share at an exercise price of US$0.90 until August 16, 2024. As of the date hereof, we have 7,667,050 Common Share purchase warrants (the “2023 Warrants”) issued and outstanding. Each 2023 ...more  
Comment by Noteable on Aug 14, 2024 8:12pm
What you spessestsemper post is totally unrelated to what I've posted . Instead you have sought to deflect away with completely irrelevant nonsense.
Comment by Noteable on Aug 14, 2024 8:13pm
spessestsemper you lack knowledge. 
Comment by spesestsemper on Aug 14, 2024 8:14pm
Well according to the filing there is no 3.5 million warrants expiring today . All you have to do is read the filing . If there were 3.5 million warrants expiring today , they would have made the filing . I'm not sure why you are finding this so hard to comprehend .
Comment by Noteable on Aug 14, 2024 8:24pm
As of August 14, 2019 the issuance of 4.619,773 warrants had been set to expired 5 years later. As of today 1.4 million were exercised leaving an outstanding total of 3,219,773 million warrants exipring at the close of trade today
Comment by Noteable on Aug 14, 2024 9:23pm
From the August 14, 2019 offering : "Oncolytics has also granted to the underwriter a 30-day option to purchase up to an additional 692,965 common shares and/or warrants to purchase up to 692,965 common shares, at the public offering price per common share and warrant, less underwriter discounts and commissions." Consequently a total of 5,312.698 warrants were issued.  With 1.4 ...more  
Comment by 13X2413 on Aug 14, 2024 8:26pm
I'm starting to feel that Notes got spanked today by Spesest.....
Comment by Noteable on Aug 14, 2024 8:31pm
Ohhh numbers ... you can't seem to get over you S&M predilections.. can you?
Comment by 13X2413 on Aug 14, 2024 8:32pm
Hold on. Googling what that means. 
Comment by Noteable on Aug 14, 2024 8:36pm
Just Google Stormy Daniel's and unpasteurized milk.
Comment by Noteable on Aug 14, 2024 8:33pm
Lower total outstanding shares appear to be threatening to some.  
Comment by Buckhenry on Aug 14, 2024 11:28pm
Below is an eye opening article: https://www.biopharmadive.com/news/biotech-startups-pharma-licensing-deals-terms-partnerships-upfront-trends/723347/
Comment by Noteable on Aug 15, 2024 12:08am
And what this biopharmdive article reveals seems to be where ONCY is at in the following comment: "Companies with more proven drug assets are prized commodities."
Comment by Buckhenry on Aug 15, 2024 1:36pm
If one reads the article in entirely and don't just read the parts that fit their narrative they will see that the pharmaceuticals are waiting for the sure thing as they have been burned too many times. Oncy appears to be in a decent position but it could still be a long wait and see game. And that's how the market sees it by the volume and stagnant price. 
Comment by Noteable on Aug 15, 2024 2:34pm
The Accelerated Pathway changes the whole time-line equation for ONCY.
Comment by Noteable on Aug 15, 2024 2:35pm
Should read: The Accelerated Approval pathway....
Comment by Noteable on Aug 15, 2024 2:36pm
By ONCY beginning the process of enrolling between 180-200 patients in a monotherapy pelareorep + paclitaxel clinical/registration study ONCY speeds up the Accelerated Approval process by demonstrating to the FDA that ONCY is well into the implementation of a well designed clinical study, with FDA agreed upon primary and secondary endpoints, that have resulted in previous Accelerated Approvals, as ...more  
Comment by Quentin30 on Aug 15, 2024 4:57pm
If ONCY had run a Phase III trial for mBC when they were granted a SPA by FDA in 2017 (or was it 18), Pela would be approved by now... Cash as of end of Q1 was 29 million... so there won't be any money left to run this trial unless they dilute shareholders significantly again... assuming cash of 15 million, this only values ONCY at 50 million... not much for a company on the cusp of ...more  
Comment by venture009 on Aug 15, 2024 7:03pm
Quentin. I agree but their hope and seems because of their finances, this may be the only play left, is sell to a big pharma. My concern is the prospects for the economy and the impact it will have on small companies under capitalized like ONC. Options become limited. 
Comment by Noteable on Aug 15, 2024 7:29pm
Just to remind you Quentin you admittedly sold all of your ONCY shares, so your belly-aching can only be viewed as highly predjudicial now that ONCY is seeking Accelerated Approvals, which you didn't believe me when I stated it was happening, and has enough cash to make things happen.  The Accelerated Approval pathway is now available for pelareorep's quick approval. Other than ...more  
Comment by venture009 on Aug 15, 2024 11:15pm
Notable, an AA  has been predicted here for a number of yeard now, so the million dollar question is can they get this approval before any radical financial procedures? If an AA is in the cards you know BP is all over it. BP is in the FDA's pocket.
Comment by Azzak34 on Aug 16, 2024 7:22am
Correction...... FDA is in BPs pocket. 
Comment by Noteable on Aug 16, 2024 9:34am
venture aka Azzak34 ??  The corrective post under Azzak34 sure looks like that.
Comment by Azzak34 on Aug 16, 2024 9:36am
Haha Noteable, that was me correcting his statement about the FDA. Just stick with the posts on pharma, you're good at that. The other stuff not so much. 
Comment by Noteable on Aug 16, 2024 9:40am
Ok. All's good.
Comment by Noteable on Aug 16, 2024 9:42am
But I think I'm still right about your dual identity even though as Azzal34 you've been stand up.
Comment by Azzak34 on Aug 16, 2024 9:55am
Nope, never had dual accounts. Cowardly people post under 2 different names for reasons I can only imagine. 
Comment by venture009 on Aug 16, 2024 8:06pm
Notable Azzark isn't me and I'm not him/her. By the way thanks for correcting my "pocket" gaffe. 
Comment by Buckhenry on Aug 17, 2024 1:10pm
Not sure why folks on here continue to worry about who is who and whether you own stock or not. Neither is a criteria for posting on here. Also subscribing to someone's woke narrative isn't either. Get over it girls.   Let's just focus on unnoteable telling us how great the stock is...
Comment by Azzak34 on Aug 17, 2024 2:43pm
President Harris is going to change our fortunes! I can feel it. 
Comment by Peladawn on Aug 17, 2024 4:15pm
Really, Azzak.....you really think her plan of handouts and subsidies to buy votes is going to reduce inflation.....I should apologize....I thought you were at least reasonably intelligent, but it appears you have the IQ of a a goldfish.....I wonder how many hundreds of billions of hard-working Americans' tax money she's going to give away to first time home buyers, like her and Biden did ...more  
Comment by Azzak34 on Aug 17, 2024 5:41pm
Have I advocated for any of her policies or her character? She's going to win with our without my endorsement, which I'll not be giving her incidentally. 
Comment by Peladawn on Aug 17, 2024 6:29pm
You just said her "presidency" (what a farce that would be) is going to change our fortunes....you can feel it!.....what is it you can feel then......early onset dimensia? ....
Comment by Azzak34 on Aug 17, 2024 6:38pm
I was just making fun of Buckster but as always you stumbled in to ruin it. She's going to win, start coping with it now and cushion the crushing blow you're going to feel. 
Comment by Peladawn on Aug 17, 2024 7:07pm
Oh well.....if voters, especially the young voters, are stupid enough to vote in another four years of what we've just had, they deserve everything they'll be in for.....
Comment by itntdf on Aug 18, 2024 9:48am
yes, it's obvious as the oracle of merde a lagoon has laid out for all to see.  it really comes down to two choices: get electrocuted or get eaten by sharks. these young voters need to spend more time on the water to understand this.
Comment by Peladawn on Aug 18, 2024 11:22am
"Electrocuted or eaten by sharks"?.....that is a fool's way of looking at it, I guess.....but, a thinking, informed voter's choice would be.........either cheap gas prices along with an end to inflation, or, continued out of control spending, along with continued higher gas prices, continued inflation, and an almost guaranteed recession.
Comment by venture009 on Aug 17, 2024 8:32pm
Azzark. they can't shelter her forever. They have been  able to so far but that will change after their convention.  The policies she has announced I don't think the American voter is that stupid to accept them. These policies will absolutely destroy the American economy.  The main concern for the American voter is the economy and border. She can't defend either. The ...more  
Comment by Noteable on Aug 16, 2024 9:39am
So yes. The prospect of an Accelerated Approval will have BP frenzied with excitement and increasingly circiling ONCY.
Comment by Noteable on Aug 16, 2024 9:46am
Should read : ... increasingly circling ONCY
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities